Boston Scientific (BSX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.98 -5.9%
Revenue Growth %: +3.7%
Financial Fact:
Operating expenses: 1.16B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.7%
Financial Fact:
Operating expenses: 1.16B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.08, $0.10 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.73 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Boston Scientific unlikely to meet forecasts after cyber attack - Bloomberg
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
